EPL Ltd Q3 FY2025 Concall Summary

Key Takeaways

• Margins and profits surge on restructuring payoff: EBITDA margin hit 20.3%, up 152 bps YoY, while adjusted PAT jumped 34%, driven by a sharp turnaround in Europe and the Americas.
• Beauty & Cosmetics is the new growth engine: B&C grew double digits globally and now makes up 48.7% of total revenue, with greenfield expansions in Thailand and Brazil set purely to capture more of this higher-value segment.
• India is the soft spot, but a fix is promised: Revenue grew just 1% in AMESA and India margins disappointed at ~17%, yet management is confident of recovering 150 bps in India margins over the next few quarters.
• The balance sheet is rapidly de-risking: Strong cash flow drove net debt-to-EBITDA down to 0.76x, while ROCE expanded 321 bps to 16.9%, positioning the company for consistent PAT growth.
• What to watch next quarter: Whether the promised India B&C momentum materializes, the pace of India margin recovery, and any update on the undisclosed Thailand capex quantum.

Margin Recovery & Profitability

• The 152 bps EBITDA jump: Driven by mix improvement toward higher-margin B&C and a strong geographic mix shift as restructured European and American operations delivered better gross margins.
• Europe turnaround mechanics: EPL was a single-digit share player "fraught with internal challenges" — manufacturing too much in Germany, costs too high, too internally focused. Structural and people interventions have transformed this, and management has been "pleasantly surprised" with the volume response.
• India margin drag: EBITDA at ~17% fell below expectations due to slow revenue growth pressuring fixed cost leverage, marginally lower gross margins from continued pricing impact and unfavorable mix, and investment in personnel costs that could not be leveraged.
• India margin recovery plan: Management is confident of bringing India margins back by about 150 bps over the next few quarters, with actions already initiated.
• Gross margin improvement of 200 bps: Driven by mix improvement and positive geography benefit as Europe and Americas results improved, delivering strong gross margins that lifted the overall mix.
• EBITDA growth ahead of revenue: Management confident of continuing this trend because multiple initiatives are still under play — Europe and America still have "some juice there," and AMESA margins have room to improve further.

Deepak Goyal: "India margins, EBITDA at about 17% is lower than our expectations. We are not happy with it."

Beauty & Cosmetics: The Strategic Pivot

• B&C now 48.7% of revenue: The segment grew double digits globally, led by robust performance in EAP and the Americas, and now approaches half the company's total business.
• B&C margin superiority: On a per-tube basis, B&C margins are significantly higher than Oral Care, driven by higher selling price. On a percentage basis they are very similar, but at the EBITDA level B&C is significantly better because fixed cost allocation as a percentage is lower with the benefit of higher revenue.
• Thailand greenfield: A focused B&C facility with tubing, printing, and modular capability, set to start production in H2 FY26. The approach is to unlock B&C first rather than entering as an oral care company.
• Thailand market logic: A ~150 crore tube market with access to Indonesia, Vietnam, and Malaysia. Salespeople have been on the ground for over a year and have developed a strong pipeline with multiple orders in the finalization stage.
• Brazil brownfield expansion: Within two years of commercialization, EPL is expanding capacity purely for B&C, which will give higher ASPs and be far better from a P&L standpoint. New capacity goes online by Q1 FY26.
• Europe B&C surge: Europe is the biggest B&C region globally, and EPL's restructured cost model and new people are now capturing share. Management has been "pleasantly surprised" by the volume response.
• China B&C acceleration: EPL is staying focused on domestic demand and accelerating efforts behind B&C, having previously only focused on converting B&C from extruded to laminated tubes. An extruded facility has been added with initial success, and expansion is being considered.

Anand Kripalu: "We believe that the high ASP margin accretive opportunity is there with Beauty & Cosmetics. And that's why we are setting up a focused Beauty & Cosmetics unit at least to start with in Thailand."

Geographic Performance & Strategy

• Low-share vs high-share strategy: In India where shares are very high, category growth is far more critical. In Europe and Brazil, it is about being competitive on innovation, service, and quality — not discounting on price.
• Export aggression: Management is "significantly increasing the aggressiveness behind getting business outside of India," with new business development headcount added and new pipelines being built. Some big customers have made significant progress that could unlock material opportunity.
• Trump tariff view: EPL does not export tubes to the US; all US-sold tubes are made in the US. Only laminates are exported from India and China. If large duties hit China, some extruded tube demand could shift to India where EPL has capacity. "We might actually benefit from the Trump tax given our geographic flexibility."

Anand Kripalu: "In the last few quarters, ever since we have made some structural and people interventions in Europe, I think that thing has started transforming. And actually, while we don't share volume numbers, we have been, I would say, pleasantly surprised with the amount of volumes that we've been getting in Europe, okay?"

Balance Sheet & Capital Allocation

• Net debt-to-EBITDA at 0.76x: Strong cash flow generation drove significant deleveraging, down from higher levels a year ago.
• ROCE at 16.9%: Expanded 321 bps YoY, reflecting both improved profitability and disciplined capital allocation.
• Capex strategy undisclosed: Management declined to disclose the quantum of capex for both the Thailand greenfield and Brazil brownfield expansions, stating the Thailand number will be disclosed at a subsequent date and that the Brazil quantum is less important than the decision to expand within two years of commercialization.
• China tax concession renewal: A concessional tax rate renewal came in December, reversing earlier provisions made at 25%. A large part of this reversal belongs to the current financial year and is not a one-off or exceptional item.
• Forex loss: Driven by volatile Brazilian and Egyptian currencies. On a full-year basis, EPL deals in some 10 currencies from East to West, providing natural coverage.

Guidance & Commitments

Key Metrics